Illustrative

FDA chief Marty Makary resigns from agency, ending tumultuous tenure

Healthcare Dive·May 12

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Marty Makary has resigned as FDA chief, ending a tenure that has been described as tumultuous and turbulent. The resignation has left the agency in transition and created uncertainty, particularly for the biotech industry. It is unclear who will lead the agency, although there are reports of changes in leadership and efforts to reform the agency's safety surveillance system.

Full coverage

Fetching the latest headlines…

FDA chief Marty Makary resigns from agency, ending tumultuous tenure

Full coverage

FDA commissioner resigns after tumultuous tenure

FDA Commissioner Marty Makary to resign, capping turbulent tenure

End of FDA Commissioner Makary’s Tumultuous Tenure Leaves Agency in Transition

Marty Makary’s Turbulent Tenure at FDA Comes to an End

FDA’s leadership void leaves biotech with renewed ‘uncertainty’

FDA names safety vet acting head of food

Vinay Prasad, controversial FDA leader, to again depart agency

FDA to unify agency’s ‘fragmented’ safety surveillance system